Detecting harmful free radicals using advanced nanodiamond sensors
Official title: Nanodiamond Quantum Sensors for Free Radical Detection
Funded at Adamas Nanotechnologies, INC. · NIH-11007965 · Data updated 2026-11-12
This study is exploring a new way to measure harmful molecules in your blood that can affect your health, using special tiny diamonds, which could help doctors find better ways to diagnose and treat diseases related to these molecules.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Adamas Nanotechnologies, INC. NIH-funded |
| Lab location | 1 site (Raleigh, UNITED STATES) |
| Project start | September 10, 2021 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,034,967 |
| NIH project number | 9R44TR005336-02 |
| Project ID | NIH-11007965 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with conditions linked to oxidative stress or free radical damage.
✕Less likely to help
Patients with conditions unrelated to oxidative stress or free radical activity may not benefit from this research.
What this research studies
This research focuses on developing a novel quantum sensing technology that can accurately measure reactive oxygen species (ROS) in biological fluids like whole blood. By utilizing nanodiamonds with unique quantum properties, the sensors aim to provide sensitive and rapid detection of free radicals, which play a crucial role in various diseases. The goal is to enhance our understanding of how these species contribute to health and disease, potentially leading to new diagnostic tools and treatment options. Patients may benefit from improved diagnostics and therapies that target ROS-related conditions.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for diseases associated with free radical misregulation.
How similar studies have gone: Other research has shown promise in using quantum sensors for biological applications, indicating potential success for this novel approach.
Where this research is happening
-
Adamas Nanotechnologies, INC.
Raleigh, United States Active
Researchers
- Principal investigator: Torelli, Marco — Adamas Nanotechnologies, INC.
- Study coordinator: Torelli, Marco
Related research
Other NIH-funded projects on the same topics.
-
Real-Time Mitochondrial Temperature Technique for Alzheimer's Disease
A tiny, advanced imaging method is being tested to measure the temperature of mitochondria in cells, which may reveal new signs of Alzheimer's disease.
-
Using nanodiamond particles to improve quantum sensing technology
This study is working on creating special diamond materials that can help improve medical imaging and diagnostics, making it easier for doctors to see what's happening in the body, which could ultimately benefit patients.
-
Tiny diamond sensors to measure free radicals in blood
Building diamond-based quantum sensors to measure reactive oxygen species (free radicals) in blood so researchers and clinicians can better understand and diagnose disease.
-
Improving MRI imaging using advanced nanoparticle technology
This study is testing a new type of MRI technology that uses special tiny particles to create clearer images of deep tissues, which could help doctors better understand diseases and improve how they diagnose and treat patients.
-
Improving nanodiamond particles for advanced sensing techniques
This study is working on tiny sensors made from nanodiamonds that can help doctors see important signals in the body, which could lead to better and faster ways to diagnose health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.